Literature DB >> 5696946

The carbohydrate structures of the neutral ceramide glycolipids in kidneys of different mouse strains with special reference to the ceramide dihexosides.

E P Adams, G M Gray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5696946     DOI: 10.1016/0009-3084(68)90018-2

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


× No keyword cloud information.
  7 in total

1.  Glycosphingolipids of white cells, lymphoid tissue and bone marrow.

Authors:  G M Levis; M Kesse-Elias
Journal:  Lipids       Date:  1974-09       Impact factor: 1.880

2.  Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals.

Authors:  Johanna von Gerichten; Kerstin Schlosser; Dominic Lamprecht; Ivan Morace; Matthias Eckhardt; Dagmar Wachten; Richard Jennemann; Hermann-Josef Gröne; Matthias Mack; Roger Sandhoff
Journal:  J Lipid Res       Date:  2017-04-03       Impact factor: 5.922

Review 3.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Differences in liver ganglioside patterns in various inbred strains of mice.

Authors:  R Ghidoni; S Sonnino; V Chigorno; B Venerando; G Tettamanti
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

5.  Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells.

Authors:  H D Klenk; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205

6.  Contribution of adhesion to bacterial persistence in the mouse urinary tract.

Authors:  L Hagberg; R Hull; S Hull; S Falkow; R Freter; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.